RTW INVESTMENTS, LP Q1 2019 Filing
Filed May 15, 2019
Portfolio Value
$1.5T
Holdings
50
Report Date
Q1 2019
Filing Type
13F-HR
All Holdings (50 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | RCKTRocket Pharmaceuticals Inc | 16,037,486 | $280.3B | 19.13% | |
| 2 | PTCTPTC Therapeutics Inc | 2,514,271 | $94.6B | 6.46% | |
| 3 | —Dicerna Pharmaceuticals Inc | 6,223,036 | $91.2B | 6.22% | |
| 4 | ALNYAlnylam Pharmaceuticals Inc | 835,873 | $78.1B | 5.33% | |
| 5 | BMYBristol Myers Squibb Co | 1,525,464 | $72.8B | 4.97% | |
| 6 | PRQRProQR Thrapeutics N V | 3,722,950 | $51.6B | 3.52% | |
| 7 | 3M4Masimo Corp | 363,569 | $50.3B | 3.43% | |
| 8 | FIXXEURHomology Medicines Inc | 1,736,719 | $48.2B | 3.29% | |
| 9 | VCELVericel Corp | 2,487,922 | $43.6B | 2.97% | |
| 10 | LIVNLivaNova PLC | 435,136 | $42.3B | 2.89% | |
| 11 | —Achillion Pharmaceuticals Inc | 13,749,383 | $40.7B | 2.78% | |
| 12 | SRPTSarepta Therapeutics Inc | 338,199 | $40.3B | 2.75% | |
| 13 | —Myokardia Inc | 706,570 | $36.7B | 2.51% | |
| 14 | AXNX*Axonics Modulation Tech Inc | 1,524,030 | $36.5B | 2.49% | |
| 15 | ADVMCHFAdverum Biotechnologies Inc | 6,256,840 | $32.8B | 2.24% | |
| 16 | ESTAEstablishment Labs Hldgs Inc | 1,325,539 | $31.9B | 2.18% | |
| 17 | AGENEURAgenus Inc | 9,883,213 | $29.4B | 2.00% | |
| 18 | ARWRArrowhead Pharmaceuticals In | 1,528,213 | $28.0B | 1.91% | |
| 19 | RGNXRegenxbio Inc | 451,182 | $25.9B | 1.76% | |
| 20 | FLBFluidigm Corp del | 1,930,934 | $25.7B | 1.75% | |
| 21 | SIBNSi bone Inc | 1,269,194 | $23.9B | 1.63% | |
| 22 | MRTXEURMirati Therapeutics Inc | 312,093 | $22.9B | 1.56% | |
| 23 | CNCEEURConcert Pharmaceuticals Inc | 1,688,448 | $20.4B | 1.39% | |
| 24 | I9DNArbutus Biopharma Corp | 5,510,223 | $19.7B | 1.35% | |
| 25 | APYXApyx Med Corp | 3,124,899 | $19.7B | 1.35% | |
| 26 | KIDSOrthopediatrics Corp | 428,142 | $18.9B | 1.29% | |
| 27 | WVEWAVE Life Sciences Ltd | 436,777 | $17.0B | 1.16% | |
| 28 | —Principia Biopharma Inc | 455,948 | $15.5B | 1.06% | |
| 29 | —Translate Bio Inc | 1,352,970 | $13.8B | 0.94% | |
| 30 | ARVNArvinas Inc | 916,514 | $13.5B | 0.92% | |
| 31 | JNJJohnson & Johnson | 84,614 | $11.8B | 0.81% | |
| 32 | CTMXCytomx Therapeutics Inc | 965,252 | $10.4B | 0.71% | |
| 33 | QUREUniqure NV | 154,058 | $9.2B | 0.63% | |
| 34 | MYGNMyriad Genetics Inc | 267,491 | $8.9B | 0.61% | |
| 35 | AXSMAxsome Therapeutics Inc | 595,635 | $8.5B | 0.58% | |
| 36 | —Odonate Therapeutics Inc | 331,240 | $7.3B | 0.50% | |
| 37 | CDNACareDx Inc | 221,663 | $7.0B | 0.48% | |
| 38 | —Chardan Healthcare Acquisiti | 600,000 | $6.0B | 0.41% | |
| 39 | —Oncocyte Corporation | 1,288,873 | $5.1B | 0.35% | |
| 40 | —Viveve Med Inc | 4,480,565 | $4.2B | 0.29% | |
| 41 | ARGXargenx SE | 30,714 | $3.8B | 0.26% | |
| 42 | ECORGBPElectrocore inc | 518,010 | $3.6B | 0.25% | |
| 43 | —Vivus Inc 4.5 05/01/2020 | 4,000,000 | $3.1B | 0.21% | |
| 44 | STIMNeuronetics Inc | 166,561 | $2.5B | 0.17% | |
| 45 | —La Jolla Pharmaceutical Co | 301,166 | $1.9B | 0.13% | |
| 46 | —Motus Gi hldgs Inc | 459,478 | $1.8B | 0.12% | |
| 47 | SLDBSolid Biosciences Inc | 141,836 | $1.3B | 0.09% | |
| 48 | VRAYQViewray Inc | 159,247 | $1.2B | 0.08% | |
| 49 | —Optinose Inc | 82,645 | $851.0M | 0.06% | |
| 50 | —Anchiano Therapeutics Ltd | 60,414 | $411.0M | 0.03% |